Therapeutic Immunogenicity: Target Interference and Cut Point Evaluation

Erik Meyer’s formal education included undergraduate studies at the University of Texas in Austin, graduate studies at Massachusetts Institute of Technology, and post-doctoral work at Texas A&M. I then joined a biotech start up, Xenomics isolating urine DNA for diagnostic analysis. At Huntingdon Life Sciences and Tandem Laboratories, I learned the nuances of Good Laboratory Practices and immune assay development for PK and immunogenicity detection, which have been useful for supporting anti-drug antibody detection for various clinical projects at GSK.